← SynDRA
LY311727
SynDRA canonical compound SYN0287582 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PLA2G2A |
|---|
| Mechanism of action | phospholipase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- LY-311727
- LY311717
- RefChem:925057
- DTXCID3090197
- OPWQYOUZRHDKBR-UHFFFAOYSA-N
- U8D
- orb1704390
- SCHEMBL7965980
- SCHEMBL29362159
- BDBM23771
- C22H27N2O5P
- PGA08384
- EX-A11248
- MFCD00943218
- AKOS024457722
- NCGC00370857-01
- MS-32789
- DS-015941
- HY-107393
- LY311727?
- CS-0028363
- LY311727, >=98% (HPLC), powder
- G12915
- T22950
- (3-{[3-(2-amino-2-oxoethyl)-1-benzyl-2-ethyl-1H-indol-5-yl]oxy}propyl)phosphonic acid
Look up LY311727 in the interactive SynDRA portal →